Media and Press Releases - Histologics LLC

Histologics' Gentle Kylon® Biopsy Brush Poised to be the New Standard of Care for Endocervical Biopsy

May 5, 2026 -- Anaheim, CA

Histologics LLC, based in Anaheim, California attended the Annual Meeting of the American Society of Colposcopy and Cervical Pathology in Orlando, FL from April 23-26, 2026. The meeting featured findings by the NIH showing that Histologics' Kylon® biopsy brushes enabled researchers to discover pre-malignant lesions in the endocervical canal and that carcinoma in-situ is present in the endocervix significantly more than previously thought.

NIH Global Study: Histologics Gentle Kylon® Biopsy Brush Shows Diagnostic Advantages in Cervical Cancer Workups

April 30, 2026, 16:07 -- Anaheim, CA

Histologics LLC, based in Anaheim California attended the Annual Meeting of the American Society of Colposcopy and Cervical Pathology in Orlando, FL from April 23-26, 2026. Mark Schiffman MD, MPH, Epidemiologist and Senior Investigator at the National Cancer Institute / National Institutes of Health led a session addressing efficient screening, triage and treatment of diagnosed high grade cervical cancer precursors performed during the "Moonshot" funded NIH PAVE (Human Papillomavirus (HPV)-Automated Visual Evaluation) study) performed in countries with significant cervical cancer death rates: Brazil, Cambodia, Dominican Republic, El Salvador, Eswatini, Honduras, Malawi, Nigeria, and Tanzania.

Histologics, LLC to Attend ASCCP Annual Scientific Meeting in Orlando, Florida

April 21, 2026, 17:00 -- Anaheim, CA

ASCCP Annual Scientific Meeting in Orlando, Florida

Histologics, LLC, the value-based leading innovator in providing devices to achieve Compassionate Colposcopy®, is excited to announce that we will be attending the upcoming American Society for Colposcopy and Cervical Pathology (ASCCP) Annual Scientific Meeting in Orlando, Florida (Renaissance Orlando at SeaWorld®) 23-25 April 2026. Being a part of this incredible community of clinicians and researchers dedicated to cervical and lower genital tract cancer prevention, diagnosis, and treatment is an honor we do not take lightly. We are especially looking forward to hearing the latest news and findings from the NIH HPV Automated Visual Evaluation (PAVE) study, presented by Mark Schiffman, MD, MPH, renowned researcher and Senior Investigator at the National Cancer Institute (NCI), National Institutes of Health.

Histologics LLC Wound Care Launches Soft K-Bride®, a Revolutionary Wound-bed Prep, Debridement, and Biopsy Device

November 6, 2025 -- Anaheim, California

Histologics LLC a leader in advanced wound care solutions, is proud to announce the launch of Soft K-Bride® a cutting-edge wound-bed preparation, debridement, and biopsy device designed to streamline wound care and enhance patient outcomes.

STELLAR SUCCESS: Leveling Up For Medical Pros with Dr. Tudor Francu

Medical Innovation with Dr. Neal Lonky

Podcast Interview STELLAR SUCCESS: Leveling Up For Medical Pros with Dr. Tudor Francu

From his roots in New York to his leadership role at Southern California Permanente Medical Group, Dr. Neal Lonky has worn many hats—physician, educator, entrepreneur, and inventor. In this conversation, he shares his journey through medicine, including his pivot from frontline care to medical device innovation, public health policy, and wound care diagnostics.

Listeners will discover how his values—persistent patience, transparency, and value–based care—have fueled a mission–driven career that goes beyond profit. Dr. Lonky also discusses what it takes to bring a medical product to market, how he navigated failures, and why compassion must be at the center of innovation.

Medical innovation and device development
Public health policy and wound care diagnostics
Value–based care and mission–driven practice
Lessons from product failures and persistence
The role of compassion in medical innovation

Listen to "Medical Innovation with Dr. Neal Lonky" on Stellar Success Podcast

Featured in CEO|CFO Magazine

Download PDF

Research Supports Compassionate New Biopsy Approach For Women's Health In Cervical Cancer Prevention

(3) Mogolia; Gynecologic Research Foundation, USA 2020 - A study conducted in concert with this not for profit organization and the National Cancer Institute evaluated a rapid, high volume system to screen, biopsy, triage and when indicated, treat women at risk of harboring high grade cervical cancer precursors. A bedside rapid colposcopic imaging system and Histologics' SoftBiopsy® device was used to diagnose women at risk who underwent treatment.